AMO (Advanced Medical Optics) closes $135 million credit facility:
This article was originally published in Clinica
Executive Summary
Ophthalmic surgical device company Advanced Medical Optics (AMO) has closed a $135m senior credit facility, as well as a $200m senior subordinated bond issue (see Clinica No 1012, p 16). The Santa Ana, California company, which is being spun off from Allergan on June 29, says the financings reflect the last major step in the spin-off activities.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.